Kusaka, Masahiro
Sakamoto, Koji
Ikeyama, Yoshiki
Kondo, Yuki
Hayashi, Tomoya
Ando, Akira
Mori, Yuta
Sato, Tomonori
Matsushima, Miyoko
Suzuki, Atsushi
Fujita, Saeka
Shiraki, Yukihiro
Kawabe, Tsutomu
Enomoto, Atsushi
Ishii, Ken J.
Hashimoto, Naozumi
Ishii, Makoto
Funding for this research was provided by:
Japan Science and Technology Agency (JPMJCR17H3)
Japan Science and Technology Agency (JPMJCR17H3)
Japan Society for the Promotion of Science (20K21599)
Japan Agency for Medical Research and Development (24gm4010025h0002)
Japan Agency for Medical Research and Development (24gm4010025h0001)
Japan Agency for Medical Research and Development (24gm4010025h0003)
Article History
Received: 1 August 2025
Revised: 23 September 2025
Accepted: 30 September 2025
First Online: 17 December 2025
Declarations
:
: Animal studies were reviewed and approved by the University Committee on Use and Care of Animals at Nagoya University Graduate School of Medicine (Approval number M230114).
: M.I. reports research funding from Nippon Boehringer Ingelheim Co., Ltd, and received a speaking fee from AstraZeneca and Boehringer Ingelheim. The other authors have no relevant financial or non-financial interests to disclose.
: Not applicable.